Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
Future Oncology (London, England)|March 13, 2010
Novel therapeutic targets for multiple myelomaAnuj Mahindra, Diana Cirstea, Noopur RajeClinical Advances in Hematology & Oncology : H&O|October 18, 2012
Clinical trials of bisphosphonates in multiple myelomaAnuj Mahindra, Samantha Pozzi, Noopur RajeHematology. American Society of Hematology. Education Program|December 5, 2025
Choosing the optimal maintenance strategy in multiple myelomaBenjamin Puliafito, Diana Cirstea, Noopur RajeCancer Journal (Sudbury, Mass.)|December 17, 2009
Future novel single agent and combination therapiesDiana Cirstea, Sonia Vallet, Noopur RajeNature Reviews. Clinical Oncology|February 22, 2012
Latest advances and current challenges in the treatment of multiple myelomaAnuj Mahindra, Jacob Laubach, Noopur Raje, et al.Best Practice & Research. Clinical Haematology|September 7, 2025
Bispecific T-cell engager therapy for multiple myelomaDiana Cirstea, Benjamin Puliafito, Bridget E Kim, et al.Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
The treatment of multiple myeloma patients not eligible for asctPaul Richardson, Jacob Laubach, Anuj Mahindra, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2014
Role of decorin in multiple myeloma (MM) bone marrow microenvironmentNeeharika Nemani, Loredana Santo, Homare Eda, et al.Ebiomedicine|July 3, 2015
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple MyelomaElizabeth O'Donnell, Anuj Mahindra, Andrew J Yee, et al.Pageof 22